Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2008, Vol. 28 Issue (7): 43-47    DOI:
    
Study on the immunogenicity of recombinant virus of pseudorabies- porcine Circovius Type 2-porcine parvovirus
Download: HTML   PDF(443KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The recombinant pseudorabies virus expressing ORF2 gene of porcine circovius type 2 and VP2 gene of porcine parvovirus was developed into trivalence genetically engineering vaccine to inject mice, and the result showed that the recombinant virus SA215(D)had lower virulence than velogenic strain which could resist the attack of PRV Fa strain and successfully induced humoral and cellular immune response in mice. This study established the foundation for the development of trivalence genetically engineering vaccine .



Key wordsPorcine Circovius Type 2      porcine parvovirus      pseudorabies virus      trivalence genetically engineering vaccine     
Received: 23 October 2007      Published: 25 July 2008
Cite this article:

. Study on the immunogenicity of recombinant virus of pseudorabies- porcine Circovius Type 2-porcine parvovirus. China Biotechnology, 2008, 28(7): 43-47.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2008/V28/I7/43

[1] LI Zhi-li, YI Xiao-ping, CHU Ju, ZHUANG Ying-ping, ZHANG Si-liang. A Microcarrier Cell Culture Process for propagating Porcine Parvovirus in PK-15 Cells[J]. China Biotechnology, 2015, 35(7): 62-67.
[2] . The establishment and preliminary application of indirect ELISA assay for the major antigenic domain of Porcine Parvovirus VP2 protein[J]. China Biotechnology, 2007, 27(9): 53-57.
[3] . Construction of Nucleic Acid Vaccine of Porcine Parvovirus and Research on Immunogenicity[J]. China Biotechnology, 2006, 26(12): 63-67.